Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    S4 Capital

    MCap

    GBP128m

    Last close

    GBP0.19

    ▲ 2.90 (18.01%)

    Diamyd Medical

    MCap

    SEK1,552m

    Last close

    SEK11.58

    ▲ 1.50 (14.88%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Recce Pharmaceuticals — Bull, Bear & Beyond – Recce Pharmaceuticals: executive interview

Recce Pharmaceuticals — Bull, Bear & Beyond – Recce Pharmaceuticals: executive interview

Recce Pharmaceuticals — 1 video in collection

More on this equity

Recce Pharmaceuticals is an innovative, clinical-stage Australian company developing novel, broad-spectrum synthetic polymer anti-infective drugs for the treatment of several infectious diseases including sepsis, complex urinary tract infections, diabetic foot infections and other bacterial skin and skin structure infections.

Listen on your preferred podcast player below:

About Bull, Bear & Beyond: Each episode features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

< Previous
Next >

You may also be interested in these:

Healthcare

Bull, Bear & Beyond – Basilea Pharmaceutica: executive interview

Healthcare

Bull, Bear & Beyond – Oryzon Genomics: executive interview